Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-015878
Filing Date
2021-07-01
Accepted
2021-07-01 17:30:19
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3460
  Complete submission text file 0001493152-21-015878.txt   4822
Mailing Address VIROPHARMA INCORP 405 EAGLEVIEW BLVD EXTON PA 19341
Business Address
WIKLER MATTHEW (Reporting) CIK: 0001195414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 211067167

Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations